HGF and neoplasm: Based on the close involvement of HGF and its receptor Met—not only in tumor development, invasion, and metastasis but also in resistance to anticancer therapies—drug discovery targeting the HGF–Met pathway has become a hot target in anticancer drug development [156,157,158,159,160].